Donghak Kim

2.5k citations
93 papers · 2.1k indexed · h-index 26
Topics
Pharmacogenetics and Drug Metabolism (69 papers)Drug Transport and Resistance Mechanisms (19 papers)Computational Drug Discovery Methods (19 papers)

In The Last Decade

Donghak Kim

91 papers receiving 2.1k citations

Peers

Donghak Kim
Comparison fields: 5 of 109
  • Pharmacology 1.0k
  • Molecular Biology 983
  • Oncology 385
  • Pharmacology 313
  • Cancer Research 257
Replace Maryam Foroozesh with:
Maryam Foroozesh United States
David M. Stresser United States
Grażyna D. Szklarz United States
Kamlesh P. Vyas United States
Yune‐Fang Ueng Taiwan
William L. Alworth United States
Petr Hodek Czechia
Johannes Doehmer Germany
Linda C. Quattrochi United States
Palaniappan Kulanthaivel United States
Donghak Kim relative to Maryam Foroozesh United States Maryam Foroozesh's profile →
Citations per field
00.5×1.5×2.4×
Maryam Foroozesh · 1×
Citations per year

Countries citing papers authored by Donghak Kim

Since Specialization
Citations

This map shows the geographic impact of Donghak Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donghak Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donghak Kim more than expected).

Fields of papers citing papers by Donghak Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donghak Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donghak Kim. The network helps show where Donghak Kim may publish in the future.

Co-authorship network of co-authors of Donghak Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Donghak Kim. A scholar is included among the top collaborators of Donghak Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donghak Kim. Donghak Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 26
3 7
4 7
5 2
6 3
7 6
8 15
9 10
10 14
11 8
12 10
13 25
14 9
15 14
16 20
17 1
18 14
19 136
20 16

About Donghak Kim

Donghak Kim is a scholar working on Pharmacology, Biochemistry and Pharmacology, having authored 93 papers that have together received 2.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (69 papers), Drug Transport and Resistance Mechanisms (19 papers) and Computational Drug Discovery Methods (19 papers). The work is most often cited by research in Pharmacology (1.0k citations), Biochemistry (159 citations) and Pharmacology (313 citations). Donghak Kim has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include F. Peter Guengerich, Young‐Jin Chun, Tsutomu Shimada, Paul R. Ortiz de Montellano, Chul‐Ho Yun, Elizabeth M. J. Gillam, Song‐Hee Han, Young‐Ran Lim, Yeo‐Jung Kwon and Sangyun Shin. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026